Tejnaksh Healthcare Ltd.

As of June 30, 2026, Tejnaksh Healthcare Ltd. carries a market capitalization of 306.74M, placing it among publicly traded companies globally. Its enterprise value stands at 306.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Tejnaksh Healthcare Ltd. has 20.31M shares outstanding.

As of June 30, 2026, Tejnaksh Healthcare Ltd. trades at a trailing price-to-earnings ratio of 25.15.

As of June 30, 2026, Tejnaksh Healthcare Ltd. trades at an EV/EBITDA multiple of 10.70 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.84 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 21.31 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 306.74M versus a market cap of 306.74M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.84M in revenue per employee across its workforce of 38.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Tejnaksh Healthcare Ltd. recorded 5.53M in income tax expense. That works out to an effective tax rate of 31.02, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 17.82M, leaving 12.49M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Tejnaksh Healthcare Ltd.'s stock has declined approximately 33.33% over the past 52 weeks. The 50-day moving average sits at 13.28, while the 200-day moving average is 14.19.

Over the twelve months ended June 30, 2026, Tejnaksh Healthcare Ltd. generated 108.01M in revenue and converted that into 12.49M in net income, yielding earnings per share of 0.59. EBITDA reached 28.66M, while operating income came in at 14.40M.

Over the twelve months ended June 30, 2026, Tejnaksh Healthcare Ltd. posted a gross margin of 90.76, reflecting its pricing power and cost economics. The operating margin of 13.33 and net profit margin of 11.56 provide insight into operational efficiency.

Tejnaksh Healthcare Ltd.'s most recent stock split took place on July 19, 2023 with a 1:2 split ratio.